Press Releases
Genetix Biotherapeutics to Present Recent Patient Experience Data from U.S. Commercial Gene Therapy Implementation at the 67th American Society of Hematology (ASH) Annual Meeting
Genetix will be presenting real-world data on access, coverage, and the patient journey in sickle cell disease and transfusion-dependent beta-thalassemia at the 67th American Society of Hematology Annual Meeting.
Read morebluebird bio Rebrands to Genetix Biotherapeutics, Returning to Its Foundational Roots
Read the full rebrand story of why we became Genetix Biotherapeutics, returning to our foundational roots and renewing our commitment to delivering transformative genetic therapies.
Read more